September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Talha Badar: Early View of the Phase 1 Study of Blinatumomab Post alloHCT
Jul 13, 2025, 14:35

Talha Badar: Early View of the Phase 1 Study of Blinatumomab Post alloHCT

Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X:

“Early View | Haematologica

Phase 1 study (Blinatumomab post alloHCT for 2 cycles among patients in CR2 (children and young adults) ALL

Most of the G4 toxicities were hematological.

Almost all patients received Blinatumomab pre-alloHCT.”

Talha Badar: Early View of the Phase 1 Study of Blinatumomab Post alloHCT

More posts featuring Blinatumomab.